| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |